Xiao Hu et al. found that the mutation of Lys448 (K448) inhibited the SUMOylation of MCT4, promoting MCT4 degradation, thereby slowing the progression of breast cancer (Hu et al., 2021). Here, SLC16A3 is linked to breast cancer.